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Abstract—Adenosine 50-triphosphate (ATP) is the main
co-transmitter accompanying the release of acetylcholine
from motor nerve terminals. Previously, we revealed the
direct inhibitory action of extracellular ATP on transmitter
release via redox-dependent mechanism. However, the
receptor mechanism of ATP action and ATP-induced
sources of reactive oxygen sources (ROS) remained not
fully understood. In the current study, using microelectrode
recordings of synaptic currents from the frog neuromuscu-
lar junction, we analyzed the receptor subtype involved in
synaptic action of ATP, receptor coupling to NADPH oxidase
and potential location of ATP receptors within the lipid rafts.
Using subtype-speciﬁc antagonists, we found that the
P2Y13 blocker 2-[(2-chloro-5-nitrophenyl)azo]-5-hydroxy-
6-methyl-3-[(phosphonooxy)methyl]-4-pyridinecarboxalde-
hyde did not prevent the depressant action of ATP. In
contrast, the P2Y12 antagonist 2-methylthioadenosine
50-monophosphate abolished the inhibitory action of ATP,
suggesting the key role of P2Y12 receptors in ATP action.
As the action of ATP is redox-dependent, we also tested
potential involvement of the NADPH oxidase, known as a
common inducer of ROS. The depressant action of extracel-
lular ATP was signiﬁcantly reduced by diphenyleneiodoni-
um chloride and 4-(2-aminoethyl)-benzenesulfonyl ﬂuoride
hydrochloride, two structurally diﬀerent inhibitors of
NADPH oxidase, indicating that this enzyme indeed medi-
ates the action of ATP. Since the location and activity of var-
ious receptors are often associated with lipid rafts, we next
tested whether ATP-driven inhibition depends on lipid
rafts. We found that the disruption of lipid rafts with
methyl-beta-cyclodextrin reduced and largely delayed the
action of ATP. Taken together, these data revealed key steps
in the purinergic control of synaptic transmission via P2Y12
receptors associated with lipid rafts, and identiﬁed NADPH
oxidase as the main source of ATP-induced inhibitory ROS
at the neuromuscular junction. Our data suggest that the
location of P2Y receptors in lipid rafts speeds up the
modulatory eﬀect of ATP. Uncovered mechanisms may con-
tribute to motor dysfunctions and neuromuscular diseases
associated with oxidative stress.  2014 IBRO. Published
by Elsevier Ltd. All rights reserved.
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INTRODUCTION
Over 30 years ago, it was demonstrated that adenosine
50-triphosphate (ATP) is released from the motor nerve
endings in the neuromuscular junction along with the
major transmitter acetylcholine (ACh) (Silinsky, 1975).
The extracellular pool of ATP, currently accepted as an
important signaling molecule for intercellular communica-
tions, may be further boosted by ATP release from peri-
synaptic Schwann cells (Liu et al., 2005) and from the
muscles (Smith, 1991; Santos et al., 2003). The latter
was ﬁrst reported in a seminal paper by Forrester and
Lind (1969). The main functional role of extracellular
ATP at the neuromuscular junction is supposed to be
the modulation of transmitter release during motor activity
(Silinsky et al., 1999) through ATP-sensitive P2 receptors
(Giniatullin and Sokolova, 1998) or via degradation to
adenosine-operating P1 receptors (Ribeiro and
Sebastia˜o, 1987, for review, Cunha and Ribeiro, 2000).
In our previous studies, we showed the direct
inhibitory action of ATP on transmitter release at the
neuromuscular junction (Giniatullin and Sokolova, 1998)
and that this eﬀect was mediated by metabotropic P2Y
presynaptic receptors coupled to speciﬁc second mes-
senger cascades (Sokolova et al., 2003; Giniatullin
et al., 2005; Grishin et al., 2005). Similarity in the action
of ATP and adenosine 50-diphosphate (ADP) (Ribeiro
and Walker, 1975) and its stable analog 2-MeSADP
(Giniatullin et al., 2005) suggested involvement of ADP-
sensitive P2Y1, P2Y12, or P2Y13 receptor subtypes as
targets for extracellular ATP in neuromuscular junction.
However, the inhibitory eﬀect of 2-MeSADP was not
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